Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it acquired 3D printing technology assets from Tissue Regeneration Systems for an undisclosed amount. DePuy said it will use the technology to create patient-specific, bioresorbable implants for correcting orthopedic and craniomaxillofacial deformities and injuries. “We are systematically investing in building a pipeline of 3D printed products. The TRS […]
Belgium-based additive manufacturer and 3D printing company Materialise said today it inked a deal with Tissue Regeneration Systems to create 3D-printed tracheal splints for use in clinical trials. Materialise said its Mimics Innovation Suite was used to design the stent, constructed from a bioresorbable platform licensed to TRS from the University of Michigan in 2007. […]
Tissue Regeneration Systems won FDA clearance for its 3D-printed Cranial Bone Void Filler, the flagship product in a suite of devices indicated for cranial reconstruction.
Designed to fill holes left behind after surgery, the CBV filler appears to be the 1st 3D-printed device of its kind to get the FDA’s green light for the U.S. market.
Startup medical device company Tissue Regeneration Systems raised $4.6 million in an equity financing round led by Venture Investors, CEO Jim Fitzsimmons told MassDevice.com.
The round was also supported by the Wisconsin Alumni Research Foundation, the University of Michigan and the state of Wisconsin, Fitzsimmons told us.